2023-507839-38-00CompletedPhase 1
A study to investigate the pharmacokinetics of a combined oral contraceptive when given alone and in combination with GSK3036656 in female participants of non-childbearing potential aged 18 to 65 years of age
Source: EU CTIS (euclinicaltrials.eu) · Last updated 21 Jun 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 22 Nov 2023
- Start date
- 5 Apr 2024
- Lead sponsor
- Glaxosmithkline Research & Development Limited
- Diseases
- Tuberculosis
- EU CT number
- 2023-507839-38-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 20
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario La Paz | Madrid | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.